Navigation Links
Mouth wash samples to predict bone marrow transplant results

Taking a sample of the mouth rinse solution can be of help to decide how far the bone marrow// transplants are successful in patients.

Oral mouth rinse of the patients of bone marrow transplant can be tested for neutrophils, which are the white blood cells that fight infection in the body. Patients of bone marrow transplant are routinely advised mouth washes to counteract the problem of mucositis that may be caused by their treatment procedure.

Researchers of University of Toronto have found that testing the basic sodium bicarbonate solutions for neutrophils may be compared with the blood test of the patients of bone marrow transplant. The research results have showed the presence of white blood cells in the sample of the mouth wash about a week before the patients’ blood samples showed the white blood cells. Researchers feel that the time difference of less than four days can be set as the parameter for the success of bone marrow transplant for the patients.

The researchers who had drawn their conclusion from parallel mouse studies are currently experimenting with discovering an easy test that will help the mouth wash samples from the patients to turn color when the white blood cells will be detected in the sample.

Reference: Bone Marrow Transplantation, June 2005
'"/>




Page: 1

Related medicine news :

1. Mouthwash as a weapon
2. Mouth Infection better handled with new discovery
3. Under Stress? All You Need Is A Chocolate To Melt In Your Mouth
4. Dentists Recommend Kids Use Mouthguard To Protect Them When Doing Sports
5. Drinking, Smoking And Unhealthy Food Linked To Mouth Cancer In Young People
6. Colgate To Develop Anti-Cancer Toothpastes And Mouthwashes
7. Oral Sex Linked To Mouth Cancer Risk
8. Foot and Mouth Disease strikes again in China
9. Foot-And-Mouth Disease of Cattle Reported In Argentina
10. Malaysia Struggles to Control Hand, Foot-and-Mouth Disease In Sarawak
11. Brunei Closes Primary Schools In A Bid To Contain Hand, Foot and Mouth Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... Pa. (PRWEB) , ... December 08, 2016 , ... ... Medicine Southern Chester County, a Property owned by an affiliate of Seavest, has ... square foot Penn Medicine Southern Chester County ambulatory care center (ACC) was named ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... access for customers and employees that are both engaging and easy to use. ... Smart Technology, the software company revealed today its plans to roll out new ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... has been recognized for adherence to the highest standards of trauma, maternity, ... organizations, announced the center's president and CEO, Dr. Daniel Messina. , Among the ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016   Hudes Laser ... December featuring the multi-wavelength Astanza Trinity laser and ... specializes in laser tattoo removal, IPL hair removal, ... ultrasound therapy. Hudes Laser Aesthetica is setting high ... and promises to deliver effective, long-lasting ...
(Date:12/9/2016)... OSAKA, Japan , Dec. 9, 2016 ... ; President & Representative Director, CEO: Dr. ... with amyotrophic lateral sclerosis (ALS) given edaravone intravenously in ... functional loss as measured by the ALS Functional Rating ... th International Symposium on ALS/MND in ...
(Date:12/9/2016)... 9, 2016  Axovant Sciences Ltd. (NYSE: ... focused on the treatment of dementia, today announced ... Phase 2b trial evaluating treatment with intepirdine (RVT-101), ... donepezil plus placebo in people with mild-to-moderate Alzheimer,s ... intepirdine to treatment was associated with reduced progression ...
Breaking Medicine Technology: